Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9650
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSingh, Aditi A.-
dc.date.accessioned2021-01-28T10:31:34Z-
dc.date.available2021-01-28T10:31:34Z-
dc.date.issued2020-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9650-
dc.descriptionGuided by Dr. Vivek Vyasen_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR00934;-
dc.subjectPPR00934en_US
dc.subjectPharmaceutical Chemistryen_US
dc.subjectBiosimilarsen_US
dc.subjectRegulatory Requirementen_US
dc.subjectDeveloped Countriesen_US
dc.subjectUSAen_US
dc.subjectEuropeen_US
dc.subjectDeveloping Countriesen_US
dc.subjectIndiaen_US
dc.titleRegulatory Requirements for Biosimilars in Developed (USA and Europe) and Developing (India) Countriesen_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR00934.pdfPPR009343.21 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.